Feb 2006

Contents in this section coming soon...

Departments

Researchers continue to make incremental progress toward a marketable retinal implant.

A new eye drop dispenser design eliminates the need to add chemicals to prevent product deterioration.

What the clinical trials tell us about how to approach AMD treatment today.

The Calhoun Light-Adjustable Lens is set to enter trials in 2006.

A two-part series looks at the role of vitrectomy in patients with uveitis.

A specialist tells how he handles four difficult situations that can arise in clinical practice.

Be cautious when basing clinical decisions on study results — not all studies are created equal.

How varying levels of hormones can have a noticeable effect on the eye.

A look at the impediments in the way of good compliance and how to overcome them.

New dual-optic, deformable and injectable IOL technology is in various stages of development.

A patient’s refraction has to be just right for him to get the most from a presbyopic IOL.